A recent study (Bergqvist et al, 2007) used quantitative real-time PCR (Q-PCR) and RNA expression profiles (RNA-EP) to evaluate HER2 status in relation to clinical outcome in breast cancer patients. Here, ERBB2 is linked to breast cancer.